(Entertainment-NewsWire.com, August 21, 2017 ) Phosphatidylserine (PS) is a phospholipid that contains both amino acids and fatty acids. The omega-3 fatty acids EPA and DHA work synergistically with PS to provide the building blocks for healthy cell membranes. The human body can make phosphatidylserine, but it obtains most of what it requires from foods.
The Global Phosphatidylserine market is estimated to reach 78.3 Million USD in 2017. On the basis of region, Asia Pacific is the largest market segment of Phosphatidylserine, followed by Europe and North America. In the report, says Dietary Supplement dominates the largest Application share in 2017. The objective of report is to define, segment, and project the market on the basis of type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows: By Type 20% Content 50% Content 70% Content
Based on region, the report describes major regions market by products and application. Regions mentioned as follows: Asia Pacific Europe North America
Based on Application, the report describes major Application share of regional market. Application mentioned as follows: Functional Foods Medical Foods
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows: Chemi Nutra Lipoid Lipogen Novastell Lonza Glonet (Doosan Group) Enzymtec Sharp.PS BHN Sino Herb H&C pharmaceutical (CSHPHARM)
